DOI: 10.12890/2025_005893
Coexistence of Philadelphia chromosome in acute promyelocytic leukaemia: two rare cases, with a literature review
Authors
Mais.musleh@damascusuniversity.edu.sy
Keywords
Acute promyelocytic leukaemia, Philadelphia chromosome, PML-RARAAbstract
Background: Acute promyelocytic leukaemia (APL) is characterised by the t(15;17)/PML::RARA translocation and typically responds favourably to differentiating agents such as all-trans retinoic acid (ATRA). The coexistence of APL with the Philadelphia chromosome (t(9;22)/BCR::ABL1), a hallmark of chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL), is extremely rare and carries uncertain prognostic and therapeutic implications.
Case description: We describe two cases where these studies confirmed APL with t(15;17)(q22;q21), in addition to t(9;22)(q34;q11), consistent with dual cytogenetic abnormalities. The patient was initiated on induction therapy with ATRA in combination with idarubicin, resulting in rapid haematologic remission by day 15, with normalisation of blood counts and significant clinical improvement.
Conclusion: These cases highlight the diagnostic and therapeutic challenges posed by APL with concurrent BCR::ABL1 rearrangement. While the PML::RARA clone responded robustly to ATRA-based therapy, the persistence of BCR::ABL1 warrants consideration of tyrosine kinase inhibitor (TKI) therapy and close molecular monitoring. Our report contributes to the limited body of literature on this rare dual-driver leukaemia and underscores the need for individualised, biology-driven management strategies.
References
- Carter BZ, Mak DH, Cortes J, Andreeff M. The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it? Semin Hematol 2010;47:362–370. doi: 10.1053/j.seminhematol.2010.06.006
- Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, et al. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood 1996;88:2236–2240.
- Mistry AR, Pedersen EW, Solomon E, Grimwade D. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev 2003;17:71–97. doi: 10.1016/s0268-960x(02)00075-9
- Sun X, He Y, Mao C, Zhu L, Qin X, Huang S. BCR/ABL fusion gene detected in acute promyelocytic leukemia: a case study of clinical and laboratory results. Leuk Lymphoma 2014;55:435–438. doi: 10.3109/10428194.2013.800870
- Mao L, Wang H, Cheng Y, Wang Y, Chen Z, Jin J. Occurrence of t(15;17)(q22;q21) and t(9;22)(q34;q11) in a patient with acute promyelocytic leukemia. Leuk Lymphoma 2009;50:466–470. doi: 10.1080/10428190802676728
- Takahashi H, Sakai R, Hattori Y, Ohshima R, Hagihara M, Kuwabara H, et al. [Biclonal co-existence of t(15;17) and t(9;22) chromosomal abnormalities in acute promyelocytic leukemia.] Rinsho Ketsueki 2011;52:37–40. Chinese.
- Preudhomme C, Lai JL, Plantier I, Demory JL, Zandecki M, Fenaux P. Cytogenetic and molecular remission in a case of acute myeloid leukaemia (AML) with inversion of chromosome 16 (Inv(16)) and Philadelphia chromosome (Ph). Br J Haematol 1992;82:623–626. doi: 10.1111/j.1365-2141.1992.tb06480.x
- Siddiqui AD, Sheikh ZS, Liu D, Seiter K. Coexistence of inversion 16 and the Philadelphia chromosome in patients with acute myelogenous leukemia. Leuk Lymphoma 2002;43:1137–1140. doi: 10.1080/10428190290021434
- Li YS, Hayhoe FG. Ph1 chromosome positive acute myelomonocytic leukaemia with inverted chromosome 16. Br J Haematol 1988;69:576. doi: 10.1111/j.1365-2141.1988.tb02422.x
- Wu Y, Slovak ML, Snyder DS, Arber DA. Coexistence of inversion 16 and the Philadelphia chromosome in acute and chronic myeloid leukemias: report of six cases and review of literature. Am J Clin Pathol 2006;125:260–266. doi: 10.1309/F0MX-5CL8-CEDY-3W86
- Zhang LJ, Gan YM, Yu L. Occurrence of BCR/ABL fusion gene in a patient with acute promyelocytic leukemia. Med Oncol 2015;32:382. doi: 10.1007/s12032-014-0382-0
